(Q31938591)

5 July 2017

De-novo humoral immune responses to cancer-associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma (English)

1 reference

5 July 2017

hepatocellular carcinoma

1 reference

inferred from title

chronic liver disease

1 reference

J Y Zhang

1

1 reference

5 July 2017

W Zhu

2

1 reference

5 July 2017

H Imai

3

1 reference

5 July 2017

K Kiyosawa

4

1 reference

5 July 2017

E K Chan

5

1 reference

5 July 2017

E M Tan

6

1 reference

5 July 2017

1 July 2001

1 reference

Clinical and Experimental Immunology

5 July 2017

1 reference

5 July 2017

125

1 reference

5 July 2017

3-9

1 reference

5 July 2017

1

1 reference

Hepatitis B virus, the vaccine, and the control of primary cancer of the liver

5 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

Hepatocellular carcinoma. A worldwide problem and the major risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

Autoantibodies in pathology and cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB x NZW)F1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

CENP-F is a .ca 400 kDa kinetochore protein that exhibits a cell-cycle dependent localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

A cell-cycle nuclear autoantigen containing WD-40 motifs expressed mainly in S and G2 phase cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

Zinedin, SG2NA, and striatin are calmodulin-binding, WD repeat proteins principally expressed in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

WD40 repeat proteins striatin and S/G(2) nuclear autoantigen are members of a novel family of calmodulin-binding proteins that associate with protein phosphatase 2A

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

New paths in human cancer serology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

Human neoplasms elicit multiple specific immune responses in the autologous host

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

The multistep nature of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

A comprehensive set of sequence analysis programs for the VAX

21 January 2018

2 references

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906107

Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers

31 October 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

Antiamphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

A survey of the humoral immune response of cancer patients to a panel of human tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

Oncogenic proteins as tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

RNA recognition: towards identifying determinants of specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

Conserved structures and diversity of functions of RNA-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

Developmental regulation of CRD-BP, an RNA-binding protein that stabilizes c-myc mRNA in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2249.2001.01585.X

Paraneoplastic neurologic syndromes: pathogenesis and physiopathology

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906107

p53 autoantibodies in the sera, cyst and ascitic fluids of patients with ovarian cancer.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906107

High frequency of neoplasia in patients with autoantibodies to centromere protein CENP-F.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906107

Genetic and structural evidence for antigen selection of anti-DNA antibodies.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906107

On global sequence alignment.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906107

Autoantibodies to a novel cell cycle-regulated protein that accumulates in the nuclear matrix during S phase and is localized in the kinetochores and spindle midzone during mitosis

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906107

Differential expression of insulin-like growth factor II mRNA in human primary liver cancers, benign liver tumors, and liver cirrhosis.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906107

Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906107

Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1906107

Circulating p53 antibodies as early markers of oral cancer: correlation with p53 alterations

31 October 2018

1 reference

12 December 2020

Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: Basis for polyvalent CT vaccine strategies

1 reference

12 December 2020

Clinical implications of p53 autoantibodies in the sera of patients with non-small-cell lung cancer

1 reference

12 December 2020

Clinical evaluation of autoantibodies to p53 protein in patients with chronic liver disease and hepatocellular carcinoma

1 reference

12 December 2020

The importance of defining the paraneoplastic neurologic disorders

1 reference

12 December 2020

Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients

1 reference

12 December 2020

Insulin-like growth factor II mRNA expression in human breast cancer

1 reference

12 December 2020

Transcripts of the insulin-like growth factors I and II in human hepatoma

1 reference

12 December 2020

Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma

1 reference

12 December 2020

Diversity of antinuclear antibody responses in hepatocellular carcinoma

1 reference

12 December 2020

Messenger ribonucleoprotein complexes containing human ELAV proteins: interactions with cytoskeleton and translational apparatus

1 reference

12 December 2020

Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas

1 reference

12 December 2020

10.1046/J.1365-2249.2001.01585.X

Identifiers

DOI

1 reference

5 July 2017

0 references

1 reference